• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYCN 扩增的胚胎性肿瘤中的脂质代谢重编程

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification.

作者信息

Talapatra Jyotirmayee, Reddy Mamatha M

机构信息

The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar 751024, India.

School of Biotechnology, KIIT Deemed to Be University, Bhubaneswar 751024, India.

出版信息

Cancers (Basel). 2023 Apr 4;15(7):2144. doi: 10.3390/cancers15072144.

DOI:10.3390/cancers15072144
PMID:37046804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10093342/
Abstract

Tumor cells reprogram their metabolism, including glucose, glutamine, nucleotide, lipid, and amino acids to meet their enhanced energy demands, redox balance, and requirement of biosynthetic substrates for uncontrolled cell proliferation. Altered lipid metabolism in cancer provides lipids for rapid membrane biogenesis, generates the energy required for unrestricted cell proliferation, and some of the lipids act as signaling pathway mediators. In this review, we focus on the role of lipid metabolism in embryonal neoplasms with MYCN dysregulation. We specifically review lipid metabolic reactions in neuroblastoma, retinoblastoma, medulloblastoma, Wilms tumor, and rhabdomyosarcoma and the possibility of targeting lipid metabolism. Additionally, the regulation of lipid metabolism by the MYCN oncogene is discussed.

摘要

肿瘤细胞会重新编程其代谢,包括葡萄糖、谷氨酰胺、核苷酸、脂质和氨基酸代谢,以满足其增加的能量需求、氧化还原平衡以及不受控制的细胞增殖对生物合成底物的需求。癌症中改变的脂质代谢为快速的膜生物发生提供脂质,产生不受限制的细胞增殖所需的能量,并且一些脂质充当信号通路介质。在本综述中,我们聚焦于脂质代谢在伴有MYCN失调的胚胎性肿瘤中的作用。我们特别综述神经母细胞瘤、视网膜母细胞瘤、髓母细胞瘤、肾母细胞瘤和横纹肌肉瘤中的脂质代谢反应以及靶向脂质代谢的可能性。此外,还讨论了MYCN癌基因对脂质代谢的调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/3c4c216305f5/cancers-15-02144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/7cbf2c1fbd58/cancers-15-02144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/e12e62f2ac9c/cancers-15-02144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/a1cc8ce51cb1/cancers-15-02144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/82def705bf74/cancers-15-02144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/3c4c216305f5/cancers-15-02144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/7cbf2c1fbd58/cancers-15-02144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/e12e62f2ac9c/cancers-15-02144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/a1cc8ce51cb1/cancers-15-02144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/82def705bf74/cancers-15-02144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84e/10093342/3c4c216305f5/cancers-15-02144-g005.jpg

相似文献

1
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification.MYCN 扩增的胚胎性肿瘤中的脂质代谢重编程
Cancers (Basel). 2023 Apr 4;15(7):2144. doi: 10.3390/cancers15072144.
2
The MYCN Protein in Health and Disease.健康与疾病中的MYCN蛋白
Genes (Basel). 2017 Mar 30;8(4):113. doi: 10.3390/genes8040113.
3
MYCN and Metabolic Reprogramming in Neuroblastoma.MYCN与神经母细胞瘤中的代谢重编程
Cancers (Basel). 2022 Aug 25;14(17):4113. doi: 10.3390/cancers14174113.
4
MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.MYCN在人横纹肌肉瘤细胞系和肿瘤样本中的表达。
J Pathol. 2002 Apr;196(4):450-8. doi: 10.1002/path.1068.
5
Childhood tumors of the nervous system as disorders of normal development.作为正常发育紊乱的儿童神经系统肿瘤
Curr Opin Pediatr. 2006 Dec;18(6):634-8. doi: 10.1097/MOP.0b013e32801080fe.
6
Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles.对三种神经源性儿童胚胎肿瘤——视网膜母细胞瘤、神经母细胞瘤和髓母细胞瘤进行代谢谱分析,可识别出不同的代谢谱。
Oncotarget. 2018 Jan 11;9(13):11336-11351. doi: 10.18632/oncotarget.24168. eCollection 2018 Feb 16.
7
Glutamine metabolism in breast cancer and possible therapeutic targets.乳腺癌中的谷氨酰胺代谢及潜在治疗靶点。
Biochem Pharmacol. 2023 Apr;210:115464. doi: 10.1016/j.bcp.2023.115464. Epub 2023 Feb 26.
8
Metabolic Reprogramming by MYCN Confers Dependence on the Serine-Glycine-One-Carbon Biosynthetic Pathway.MYCN 介导的代谢重编程导致对丝氨酸-甘氨酸-一碳生物合成途径的依赖性。
Cancer Res. 2019 Aug 1;79(15):3837-3850. doi: 10.1158/0008-5472.CAN-18-3541. Epub 2019 May 14.
9
MYCN gene amplification in rhabdomyosarcoma.横纹肌肉瘤中的MYCN基因扩增
Cancer. 1994 Apr 15;73(8):2231-7. doi: 10.1002/1097-0142(19940415)73:8<2231::aid-cncr2820730832>3.0.co;2-e.
10
Tumor metabolic reprogramming in lung cancer progression.肺癌进展中的肿瘤代谢重编程
Oncol Lett. 2022 Jun 28;24(2):287. doi: 10.3892/ol.2022.13407. eCollection 2022 Aug.

引用本文的文献

1
Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment Outcomes.解读髓母细胞瘤:驱动肿瘤发生和治疗结果的表观遗传与代谢变化
Biomedicines. 2025 Aug 4;13(8):1898. doi: 10.3390/biomedicines13081898.
2
Targeting tumor angiogenesis and metabolism: a new perspective in pediatric thoracic tumor therapy.靶向肿瘤血管生成与代谢:小儿胸部肿瘤治疗的新视角
Front Cell Dev Biol. 2025 Mar 27;13:1558403. doi: 10.3389/fcell.2025.1558403. eCollection 2025.
3
Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line.

本文引用的文献

1
Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma.髓母细胞瘤中代谢重编程的病理意义及其治疗潜力
Front Cell Dev Biol. 2022 Oct 19;10:1007641. doi: 10.3389/fcell.2022.1007641. eCollection 2022.
2
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer.通过整合结直肠癌中与代谢相关的基因特征鉴定 CPT2 作为预后生物标志物。
BMC Cancer. 2022 Oct 4;22(1):1038. doi: 10.1186/s12885-022-10126-0.
3
MYCN and Metabolic Reprogramming in Neuroblastoma.
下一代 HSP90 抑制剂 XL-888 和 Debio0932 在神经母细胞瘤细胞系中的抗癌作用的分子途径。
Med Oncol. 2024 Jul 3;41(8):194. doi: 10.1007/s12032-024-02428-z.
4
Evolving Diagnostic and Treatment Strategies for Pediatric CNS Tumors: The Impact of Lipid Metabolism.小儿中枢神经系统肿瘤不断发展的诊断和治疗策略:脂质代谢的影响
Biomedicines. 2023 May 5;11(5):1365. doi: 10.3390/biomedicines11051365.
MYCN与神经母细胞瘤中的代谢重编程
Cancers (Basel). 2022 Aug 25;14(17):4113. doi: 10.3390/cancers14174113.
4
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma.MYCN 驱动的脂肪酸摄取是神经母细胞瘤的代谢脆弱性。
Nat Commun. 2022 Jun 28;13(1):3728. doi: 10.1038/s41467-022-31331-2.
5
Lipid metabolism of cancer stem cells.癌症干细胞的脂质代谢
Oncol Lett. 2022 Apr;23(4):119. doi: 10.3892/ol.2022.13239. Epub 2022 Feb 9.
6
Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.脑髓母细胞瘤脑脊液显示出缺氧和癌症特异性 RNA 指示的代谢物和脂质。
Acta Neuropathol Commun. 2022 Feb 24;10(1):25. doi: 10.1186/s40478-022-01326-7.
7
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
8
The Oncogene Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma.癌基因调节糖酵解和侵袭基因以增强人视网膜母细胞瘤的细胞活力和迁移能力。
Cancers (Basel). 2021 Oct 19;13(20):5248. doi: 10.3390/cancers13205248.
9
Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma.抑制脂质代谢对横纹肌肉瘤发挥抗肿瘤作用。
Cancer Med. 2021 Sep;10(18):6442-6455. doi: 10.1002/cam4.4185. Epub 2021 Sep 2.
10
The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.ELOVL4 的表达受 MYCN 抑制,可定义预后良好的神经母细胞瘤患者。
Oncogene. 2021 Sep;40(38):5741-5751. doi: 10.1038/s41388-021-01959-3. Epub 2021 Jul 31.